Fremman Capital
Overview
Fremman Capital is a pan-European private equity firm that partners with management teams to transform businesses from local champions into multinational leaders across the business & tech services, healthcare, consumer goods & distribution, and industrials sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Bollo Natural Fruit | Dec 2022 | M&A | Lead |
| Stingray Healthcare Group | Oct 2025 | M&A | Co-investor |
For institutional investors. Book with your work email.
Key People
Stefan Lindemann
Head of Investor Relations
Jonathan Baensch
Investor Relations
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Fremman Capital based?
Fremman Capital is headquartered in London, United Kingdom.
When was Fremman Capital founded?
Fremman Capital was founded in 2020.
How many portfolio companies does Fremman Capital have?
Fremman Capital has 12 portfolio companies in Caplight's dataset.
What are some companies in Fremman Capital's portfolio?
Portfolio companies visible on Caplight include Bollo Natural Fruit, Stingray Healthcare Group.
What was Fremman Capital's most recent investment shown here?
Fremman Capital's most recent investment in this portfolio sample was in Stingray Healthcare Group in 2025.
What sectors does Fremman Capital focus on?
Fremman Capital focuses on Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Energy & Sustainability, Mobility, Transportation & Logistics, Energy & Sustainability, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Fremman Capital focus on?
Fremman Capital typically invests at the MultiStage stage.
What is Fremman Capital's AUM?
Fremman Capital's assets under management are estimated between $2.8B and $2.8B.